{"id":51101,"date":"2022-11-21T22:02:26","date_gmt":"2022-11-21T21:02:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/"},"modified":"2022-11-21T22:02:26","modified_gmt":"2022-11-21T21:02:26","slug":"urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/","title":{"rendered":"UroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference"},"content":{"rendered":"
\n

\n– Fireside Chat November 29, 2022 from 3:55 \u2013 4:15 PM ET –<\/i>\n<\/p>\n

PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in a virtual fireside chat at the upcoming Evercore ISI 5th Annual HealthCONx Conference on November 29, 2022 at 3:55 PM ET.\n<\/p>\n

<\/a><\/p>\n

\nA live audio webcast will be available in the “Events and Presentations<\/a>” section of UroGen\u2019s investor website. A replay will be available for approximately 30 days.\n<\/p>\n

\nAbout UroGen Pharma Ltd.<\/b>\n<\/p>\n

\nUroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGel\u2122 reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen\u2019s sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. Jelmyto\u00ae (mitomycin) for pyelocaliceal solution and investigational treatment UGN-102 (mitomycin) for intravesical solution are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit www.urogen.com<\/a> to learn more or follow us on Twitter, @UroGenPharma.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nINVESTOR CONTACT:<\/b>
Vincent Perrone
\n
Senior Director, Investor Relations
\n
vincent.perrone@urogen.com<\/a>
609-460-3588 ext. 1093\n<\/p>\n

\nMEDIA CONTACT:<\/b>
Cindy Romano
\n
UroGen Corporate Communications
\n
cindy.romano@urogen.com<\/a>
908-963-7827\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

– Fireside Chat November 29, 2022 from 3:55 \u2013 4:15 PM ET – PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in a virtual fireside chat at the upcoming Evercore ISI 5th Annual HealthCONx … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51101","6":"format-standard","7":"category-industry"},"yoast_head":"\nUroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"– Fireside Chat November 29, 2022 from 3:55 \u2013 4:15 PM ET – PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in a virtual fireside chat at the upcoming Evercore ISI 5th Annual HealthCONx ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-21T21:02:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221121005687\/en\/1644076\/21\/UroGen_logo2_%28R%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"UroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference\",\"datePublished\":\"2022-11-21T21:02:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/\"},\"wordCount\":249,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005687\\\/en\\\/1644076\\\/21\\\/UroGen_logo2_%28R%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/\",\"name\":\"UroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005687\\\/en\\\/1644076\\\/21\\\/UroGen_logo2_%28R%29.jpg\",\"datePublished\":\"2022-11-21T21:02:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005687\\\/en\\\/1644076\\\/21\\\/UroGen_logo2_%28R%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221121005687\\\/en\\\/1644076\\\/21\\\/UroGen_logo2_%28R%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/","og_locale":"en_US","og_type":"article","og_title":"UroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference - Pharma Trend","og_description":"– Fireside Chat November 29, 2022 from 3:55 \u2013 4:15 PM ET – PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in a virtual fireside chat at the upcoming Evercore ISI 5th Annual HealthCONx ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-21T21:02:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221121005687\/en\/1644076\/21\/UroGen_logo2_%28R%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"UroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference","datePublished":"2022-11-21T21:02:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/"},"wordCount":249,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221121005687\/en\/1644076\/21\/UroGen_logo2_%28R%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/","url":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/","name":"UroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221121005687\/en\/1644076\/21\/UroGen_logo2_%28R%29.jpg","datePublished":"2022-11-21T21:02:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221121005687\/en\/1644076\/21\/UroGen_logo2_%28R%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221121005687\/en\/1644076\/21\/UroGen_logo2_%28R%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/urogen-pharma-to-present-at-evercore-isi-5th-annual-virtual-healthconx-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"UroGen Pharma to Present at Evercore ISI 5th Annual Virtual HealthCONx Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51101","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51101"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51101\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51101"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51101"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51101"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}